Direct immunofluorescence testing for panniculitis offers negligible diagnostic utility: A retrospective single-center cohort study of 87 specimens - 19/08/25
Doi : 10.1016/j.jaad.2025.04.056
Seneca D. Hutson, MD a, Heather D. Hardway, PhD a, Shruti Agrawal, MD a, b, Emma F. Johnson, MD a, b, Afsaneh Alavi, MD a, Julia S. Lehman, MD a, b, ⁎ 
a Department of Dermatology, Mayo Clinic, Rochester, Minnesota
b Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
∗Correspondence to: Julia S. Lehman, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55902Department of DermatologyMayo Clinic200 First St SWRochesterMN55902
Key words : calciphylaxis, dermatopathology, direct immunofluorescence, erythema nodosum, general dermatology, immunoglobulin, lipodermatosclerosis, medical dermatology, panniculitis, polyarteritis nodosa
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Reviewed and approved by Mayo Clinic IRB (22-000049). |
© 2025
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 93 - N° 3
P. 774-775 - septembre 2025 Retour au numéro
Article précédent
- GLP-1 agonists may modulate treatment efficacy in central centrifugal cicatricial alopecia
- Noelle Desir, Iain Noel Encarnacion, Nicholas Schell, Ikenna Anusionwu, Temitayo A. Ogunleye, Susan C. Taylor
- Racial disparities in the diagnosis and treatment of dermatofibrosarcoma protuberans
- Anjana Srikumar, Raghav Tripathi, Shirley Lin, Tara McCaffrey, Elena Wei, Kristin Bibee, Joel Sunshine
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?